Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_assertion type Assertion NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_head.
- NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_assertion description "[Compared with double noncarriers (angiotensinogen -20aa and ACE II), double heterozygotes (ac-I/D genotype), and double homozygotes (cc-DD) had hazard ratios for atrial fibrillation of 1.2 (0.9-1.6; P = 0.06) and 2.4 (1.4-4.1; P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_provenance.
- NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_assertion evidence source_evidence_literature NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_provenance.
- NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_assertion SIO_000772 18496132 NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_provenance.
- NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_assertion wasDerivedFrom lhgdn-20090331 NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_provenance.
- NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_assertion wasGeneratedBy ECO_0000203 NP185319.RAtt3uJspNpS6hA2HzLa6xDoHmnw4vMltWPAags74NRFY130_provenance.